IMC Chicago
HRMY icon

IMC Chicago’s Harmony Biosciences HRMY Stock Holding History

IMC Chicago’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$479K Buy
17,100
+1,200
+8% +$39.3K ﹤0.01% 4083
2025
Q4 		$595K Buy
15,900
+100
+0.6% +$3.29K ﹤0.01% 3367
2025
Q3 		$435K Buy
+15,800
New +$544K ﹤0.01% 3255

Other funds holding HRMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

IMC Chicago's HRMY Position: Q1 2026 in Review

IMC Chicago opened a new position in Harmony Biosciences (HRMY) in Q1 2026: 11,765 shares worth $330K. The stake represents ﹤0.01% of the portfolio and ranks #4481 among its holdings.

309 funds tracked by Wall St. Rank hold HRMY as of Q1 2026.

  • IMC Chicago held 11,765 shares of Harmony Biosciences worth $330K as of Q1 2026.
  • Harmony Biosciences was a new IMC Chicago position in Q1 2026.
  • Harmony Biosciences made up ﹤0.01% of IMC Chicago's portfolio in Q1 2026, its #4481 holding.
  • 309 funds tracked by Wall St. Rank held Harmony Biosciences as of Q1 2026.

Based on IMC Chicago's 13F filing for Q1 2026, filed 5 May 2026.